Thermo Fisher Reportedly Considers To Buy Diagnostics Firm Qiagen

(RTTNews) - Thermo Fisher Scientific Inc. (TMO), the maker of diagnostic equipment, is considering a purchase of molecular testing firm Qiagen NV (QGEN, QGENF), Bloomberg reported citing people familiar with the matter.

The Dutch company Qiagen, which is listed in New York and Frankfurt, has a market value of about $8 billion as of Wednesday's close.

There's no certainty the discussion will lead to a deal, and other bidders for Qiagen could emerge, the report said.

QGEN closed Wednesday regular trading at $35.45, up $3.19 or 9.89 percent. In the after-hours, the stock further gained $0.70 or 1.97 percent.